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The Journal of Hip Preservation Surgery (JHPS) is not the
only place where work in the field of hip preservation may
be published. Although our aim is to offer the best of the
best, we continue to be fascinated by work that finds its
way into journals other than our own. There is much to
learn from it so JHPS has selected six recent and topical
articles for those who seek a brief summary of what is tak-
ing place in our ever-fascinating world of hip preservation.
What you see here are the mildly edited abstracts of the
original articles, to give them what JHPS hopes is a more
readable feel. If you are pushed for time, what follows
should take you no more than 10min to read. So here
goes . . .
PAIN MANAGEMENT STRATEGIES AFTER HIP
ARTHROSCOPY
Post-operative pain management can be an issue after hip
arthroscopy and each of us endeavours to provide the best
regime for the patients. Kahlenberg et al. [1] from North
Western University, Chicago set up a randomised con-
trolled trial to determine the efficacy of pre-operative
Celecoxib for early post-operative pain management in hip
arthroscopy in terms of reduction in pain, narcotic require-
ment and early discharge.
Ninety-eight patients were randomised to either the
Celecoxib group (n¼ 50) or the placebo group (n ¼ 48).
A priori power analysis was done, set to detect a difference
of 0.50 on the visual analogue scale (VAS), based on the
senior author’s preference. The number of patients
planned for recruitment was rounded up to 100 to allow
for flexibility in the study. Inclusion criteria were any pa-
tient at least 18 years old who underwent hip arthroscopy
surgery performed by the senior author. All patients had
less than To¨nnis grade two arthritis. Exclusion criteria were
allergy to sulpha-based drugs, prior adverse reaction to cel-
ecoxib, or patients who were on chronic narcotics for
whom alternative pain management regimens were
arranged before surgery. Randomisation was performed on
one:one basis in blocks of 10 using sealed envelopes stating
celecoxib or placebo. One hour before surgery, all patients
received either 400mg celecoxib or placebo. Patients were
evaluated using a VAS pre-operatively, immediately post-
operatively, and at 1 and 2 h post-operatively. Time from
the operating room to ‘ready for discharge’ and number of
morphine equivalents of narcotic medication required in
the post-anaesthesia care unit were recorded.
Age and pre-operative VAS were similar between the
celecoxib and placebo control group, with average ages of
34.2 and 35.8 (P¼ 0.27) years and pre-operative VAS of
2.1 and 2.3 (P¼ 0.29), respectively. The celecoxib group
had 26 females and 24 males, whereas the placebo group
had 29 females and 19 males (P¼ 0.42). The most com-
mon surgical procedures were labral repair (31 patients in
the celecoxib group and 29 patients in the placebo group),
and labral repair with acetabular osteoplasty (13 patients in
the celecoxib group and 11 patients in the placebo group).
There were no significant differences in procedures per-
formed between the two groups (P> 0.05). At 1 h post-
operatively, patients who received celecoxib had a lower
pain score that was statistically significant compared with
the placebo group (4.6 vs. 5.4, P ¼ 0.03). There was a sig-
nificant difference in discharge time between patients who
received celecoxib and the control group (152.9 vs.
172.9min, P¼ 0.04). There was no significant difference
found in morphine equivalents consumed in the post-
anaesthesia care unit between the two groups (15.3 vs.
15.4, P ¼ 0.48).
The authors concluded that a pre-operative dose of
400mg of celecoxib led to statistically significantly reduced
patient-reported pain on the VAS in the acute post-opera-
tive period after hip arthroscopy surgery, though the differ-
ence is not likely clinically significant. There was a
significantly shorter time to discharge in patients who
received celecoxib versus placebo.
ROLE OF HIP ARTHROSCOPY IN PAINFUL HIPS
WITH NORMAL IMAGING
Many practitioners have encountered patients with hip
pain that can be a diagnostic dilemma. Australian re-
searchers [2] set out to explore the role of hip arthroscopy
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in this group of complex patients with groin, hip and pelvic
pain but normal findings on magnetic resonance imaging
(MRI) and minimal changes on X-ray. They looked at the
arthroscopic findings of patients who have had hip pain
and a positive response to an intra-articular anaesthetic but
have non-contributory imaging. They hypothesised that
standard MRIs were missing significant pathology and if
there was a response to intra-articular local anaesthesia, it
was likely that there will be a pathology found during
arthroscopy.
They retrospectively reviewed all hip arthroscopies per-
formed from March 2011 to January 2015 by two ortho-
paedic surgeons specialising in hip arthroscopy to identify
patients with clinically suspected intra-articular hip path-
ology despite a normal imaging. Fifty-three hip arthroscop-
ies performed in 51 patients met the inclusion criteria from
a total of 1348 hip arthroscopies performed over a 46-
month period. All but one of the 53 (98%) hips had
arthroscopically confirmed pathology. Mean patient age
was 32.5 years (15–67) with 40 (78%) females and 11
(22%) males. 92.5% of the hips (49/53) were FADIR
(flexion, adduction and internal rotation) positive on clin-
ical examination, giving this test a positive predictive value
of 98% (95% CI: 89.31–99.67%) for intra-articular
pathology.
In conclusion, in patients with a normal MRI without
contrast and a positive response (relief of pain) to an intra-
articular injection that failed conservative management,
there is a 98% chance of intra-articular hip pathology being
discovered on hip arthroscopy.
DEFINING MODES OF FAILURE AFTER JOINT-
PRESERVING SURGERY OF THE HIP
Joint-preserving surgery of the hip (JPSH) has evolved
considerably and there are a number of different factors
that potentially can lead to failure. Consequently, it is of
interest to assess the various modes of failure in order to
continue to identify best practice and the indications for
these procedures.
Beaule´ et al. [3] from Ottawa, Canada using a retro-
spective observational study design, reviewed 1013 patients
who had undergone JPSH by a single surgeon between
2005 and 2015. There were 509 men and 504 women with
a mean age of 39 years (16–78). Of the 1013 operations,
783 were arthroscopies, 122 surgical dislocations and 108
peri-acetabular osteotomies (PAO). They analysed the
overall failure rates and modes of failure. Re-operations
were categorised into four groups: Mode 1 was arthritis
progression or organ failure leading to total hip arthro-
plasty (THA); Mode 2 was an Incorrect diagnosis/proced-
ure; Mode 3 resulted from malcorrection of femur
(type A), acetabulum (type B) or labrum (type C) and
Mode 4 resulted from an unintended consequence of the
initial surgical intervention.
At a mean follow-up of 2.5 years, there had been 104 re-
operations (10.2%) with a mean patient age of 35.5 years
(17–64). There were 64 Mode 1 failures (6.3%) at a mean
of 3.2 years following JPSH with a mean patient age of
46.8 years. There were 17 Mode 2 failures (1.7%) at a
mean of 2.2 years post-JPSH with a mean patient age of
28.9 years (2% scopes; 1% surgical dislocations). There
were 19 Mode 3 failures (1.9%) at a mean of 2.0 years
post-JPSH, with a mean patient age of 29.9 years (2%
scopes; 2% surgical dislocations; 5% PAO). There were
four Mode four failures (0.4%) at a mean of 1.8 years post-
JPSH with a mean patient age of 31.5 years. Using the
modified Dindo–Clavien classification system, the overall
complication rate among JPSHs was 4.2%.
The authors concluded that while defining the overall
re-operation and complication rates, it is important to de-
fine the safety and effectiveness of JPSH. Standardisation
of the modes of failure may help identify the best practice.
Application of these modes to large clinical series, such as
registries, will assist in further establishing how to improve
the efficacy of JPSH.
ROLE OF HIP ARTHROSCOPY IN
REALIGNMENT SURGERY FOR STABLE SLIPPED
CAPITAL FEMORAL EPIPHYSIS
Surgeons are pushing the boundaries of hip arthroscopic
intervention and Roos et al. [4] from Passo Fundo, Brazil
have extended its role in deformity correction in slipped
capital femoral epiphysis (SCFE). This study aimed to
evaluate the clinical and radiographic outcomes, as well as
the complications of arthroscopic subcapital realignment
osteotomy in chronic and stable SCFE.
Between June 2012 and December 2014, seven patients
underwent arthroscopic subcapital realignment osteotomy
in chronic and stable SCFE. The mean age was 11 years
and 4months, and the mean follow-up period was
16.5months (6–36). Clinical results were evaluated using
the Modified Harris Hip Score (MHHS), which was meas-
ured pre- and post-operatively. Radiographs were evaluated
using the Southwick quantitative classification and the
epiphysis–diaphysis angle (pre- and post-operatively).
The mean pre-operative MHHS was 35.8 points, and
97.5 points post-operatively (P< 0.05). Radiographically,
five patients were classified as Southwick classification
grade II and two as grade III. The mean correction of the
epiphysis–diaphysis angle was 40. No immediate post-
operatively complications were observed. One patient
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presented femoral head avascular necrosis, without collapse
or chondrolysis at the most recent follow-up (22months).
The authors concluded that their arthroscopic tech-
nique for subcapital realignment osteotomy in chronic and
stable SCFE showed satisfactory short-term clinical and
radiographic outcome.
DOES PERIACETABULAR OSTEOTOMY
COMPROMISE THE BONE BIRTH CANAL?
Traditionally, it is believed that periacetabular osteotomy
(PAO) would not compromise the pelvic dimensions and
would not be a relative indication for Caesarean section.
Japanese researchers [5] have undertaken a three-
dimensional computed tomography analysis on bony birth
canal after bilateral periacetabular osteotomy. They have
traditionally performed the curved periacetabular osteot-
omy (CPO) for developmental dysplasia of the hip. CPO
requires osteotomy of the medial wall of the acetabulum,
which may cause narrowing of the bony birth canal and
this step may result in increased risk of caesarean delivery.
They analysed the narrowest part of the bony birth
canal using three-dimensional computed tomography
(3 D-CT) before and after bilateral CPO. The study
included 29 cases of bilateral CPO performed between
February 2007 and March 2014 in which both pre- and
post-operative 3 D-CT were available. Transverse diam-
eters of the pelvic inlet, contraction, outlet, expansion and
teardrop were analysed. Among them, the narrowest part
of the bony birth canal was investigated, which if smaller
than the normal lower threshold value for vaginal delivery
(95mm) was considered as a risk for Caesarean delivery.
The transverse diameters of both pelvic expansion and
teardrop significantly decreased after CPO (both
P< 0.01), while other diameters showed no significant
changes. Amongst these two diameters, the narrowest
diameter of the bony birth canal was the pelvic teardrop in
all 29 cases. That in 24 patients (82.8%) was greater than
95mm, while that in five patients (17.2%) showed less
than 95mm.
The authors concluded that based on 3 D-CT analysis,
the narrowest part of the bony birth canal after bilateral
CPO was the pelvic teardrop and because in more than
80% the diameter was greater than 95mm; there was no
real contraindication for vaginal delivery in the majority.
ROLE OF PAO VERSUS ACETABULAR RIM
TRIMMING IN THE TREATMENT OF
IMPINGEMENT CAUSED BY ACETABULAR
RETROVERSION
Acetabular retroversion can cause femoroacetabular im-
pingement leading to hip pain and osteoarthritis. It can be
treated by anteverting PAO or acetabular rim trimming
with refixation of the labrum. There is increasing evidence
that acetabular retroversion is a rotational abnormality of
the entire hemipelvis and not a focal overgrowth of the an-
terior acetabular wall, which favours an anteverting PAO.
However, it is unknown if this larger procedure would be
beneficial in terms of survivorship and improvement in
functional outcome in a midterm follow-up compared with
rim trimming.
Zurmuhle et al. [6] from Bern, Switzerland have per-
formed a retrospective, comparative study evaluating the
midterm survivorship of two matched patient groups with
symptomatic acetabular retroversion undergoing either
anteverting PAO or acetabular rim trimming through a sur-
gical hip dislocation. Acetabular retroversion was defined
by concomitant positive crossover, posterior wall and is-
chial spine signs.
A total of 279 hips underwent a surgical intervention
for acetabular retroversion at Bern University hospital be-
tween 1997 and 2012 (166 periacetabular osteotomies,
113 rim trimmings through surgical hip dislocation).
A total of 99 patients (60%) were excluded from the PAO
group and 56 patients (50%) from the rim-trimming group
because they had pre-specified conditions for exclusion, for
purposes of matching, deficient records or the patient
declined or was lost to follow-up.
This left 67 hips (57 patients) that underwent antevert-
ing PAO and 57 hips (52 patients) that had acetabular rim
trimming. The two groups did not differ in terms of age,
sex, body mass index, pre-operative ROM, pre-operative
Merle d’Aubigne´-Postel score, radiographic morphology of
the acetabulum (except total and anterior acetabular cover-
age), alpha angle, To¨nnis grade of osteoarthritis and labral
and chondral lesions on the preoperative MRI. A minimum
follow-up of 2 years was required for this study. Failures
were included at any time. The median follow-up for the
anteverting PAO group was 9.5 years (range, 2–17.4 years)
and 6.8 years (range, 2.2–10.5 years) for the rim trimming
group (P< 0.001). Kaplan–Meier survivorship analysis
was performed using the following endpoints at 5 and
10 years: THA, radiographic progression of osteoarthritis
by one To¨nnis grade and/or Merle d’Aubigne´-Postel score-
< 15 points.
Although the 5-year survivorship of the two groups was
not different with the numbers available; 86% for antevert-
ing PAO versus 86% for acetabular rim trimming, the study
found increased survivorship at 10 years in hips undergoing
anteverting PAO for acetabular retroversion (79%) com-
pared with acetabular rim trimming (23%) at 10 years
(P< 0.001). The drop in the survivorship curve for the
acetabular rim trimming through surgical hip dislocation
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group started at year six. The main reason for failure was a
decreased Merle d’Aubigne´ score.
The authors concluded that anteverting PAO may be
the more appropriate treatment for hips with substantial
acetabular retroversion. This may be the result of reduction
of an already smaller lunate surface of hips with acetabular
retroversion through rim trimming. However, rim trim-
ming may still benefit hips with acetabular retroversion in
which only one or two of the three signs are positive. The
authors recommended that future randomised studies
should compare these treatments.
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